Risk of major congenital malformations following first-trimester exposure to vaginal azoles used for treating vulvovaginal candidiasis: a population-based retrospective cohort study

Fluconazole use and birth defects in the National Birth Defects Prevention Study

(2016) Meredith M. Howley et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Use of Oral Fluconazole during Pregnancy and the Risk of Birth Defects

(2013) Ditte Mølgaard-Nielsen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bias Toward the Null Hypothesis in Pregnancy Drug Studies That Do Not Include Data on Medical Terminations of Pregnancy: The Folic Acid Antagonists

(2011) Amalia Levy et al.   JOURNAL OF CLINICAL PHARMACOLOGY

A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality

(2011) Peter C. Austin   MULTIVARIATE BEHAVIORAL RESEARCH

Are azole fungicides a teratogenic risk for human conceptus?

(2010) E. Giavini et al.   TOXICOLOGY LETTERS

Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations

(2009) Ilan Matok et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Antifungal drugs and the risk of selected birth defects

(2008) Tonia C. Carter et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study

(2008) M. Norgaard et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY